Guangdong Provincial Key Laboratory of Virology, Institute of Medical Microbiology, Jinan University, Guangzhou, China.
Laboratory Animal Center, Guangzhou University of Chinese Medicine, Guangzhou, China.
J Med Virol. 2020 Apr;92(4):424-432. doi: 10.1002/jmv.25685. Epub 2020 Feb 7.
Coronaviruses (CoVs) are by far the largest group of known positive-sense RNA viruses having an extensive range of natural hosts. In the past few decades, newly evolved Coronaviruses have posed a global threat to public health. The immune response is essential to control and eliminate CoV infections, however, maladjusted immune responses may result in immunopathology and impaired pulmonary gas exchange. Gaining a deeper understanding of the interaction between Coronaviruses and the innate immune systems of the hosts may shed light on the development and persistence of inflammation in the lungs and hopefully can reduce the risk of lung inflammation caused by CoVs. In this review, we provide an update on CoV infections and relevant diseases, particularly the host defense against CoV-induced inflammation of lung tissue, as well as the role of the innate immune system in the pathogenesis and clinical treatment.
冠状病毒(CoVs)是迄今为止已知的最大的正链 RNA 病毒群,具有广泛的天然宿主范围。在过去的几十年中,新出现的冠状病毒对全球公共卫生构成了威胁。免疫反应对于控制和消除 CoV 感染至关重要,然而,失调的免疫反应可能导致免疫病理学和肺气体交换受损。深入了解冠状病毒与宿主固有免疫系统之间的相互作用可能有助于阐明肺部炎症的发生和持续发展,并有望降低 CoV 引起的肺部炎症的风险。在这篇综述中,我们提供了关于 CoV 感染和相关疾病的最新信息,特别是宿主对 CoV 诱导的肺组织炎症的防御,以及固有免疫系统在发病机制和临床治疗中的作用。